27923741|t|NLRP3 inflammasome activation contributes to long-term behavioral alterations in mice injected with lipopolysaccharide
27923741|a|Lipopolysaccharide (LPS) might affect the central nervous system by causing neuroinflammation, which subsequently leads to brain damage and dysfunction. In this study, we evaluated the role of nod-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome activation in long-term behavioral alterations of 8- week -old male C57BL/6 mice injected intraperitoneally with LPS (5mg/kg). At different time points after injection, we assessed locomotor function with a 24-point neurologic deficit scoring system and the rotarod test; assessed recognition memory with the novel object recognition test; and assessed emotional abnormality (anhedonia and behavioral despair) with the tail suspension test, forced swim test, and sucrose preference test. We also assessed protein expression of NLRP3, apoptosis-associated speck-like protein (ASC), and caspase-1 p10 in hippocampus by Western blotting; measured levels of interleukin (IL)-1β, IL-18, tumor necrosis factor α (TNFα), and IL-10 in hippocampus; measured TNFα and IL-1β in serum by ELISA; and evaluated microglial activity in hippocampus by Iba1 immunofluorescence. We found that LPS - injected mice displayed long-term depression -like behaviors and recognition memory deficit; elevated expression of NLRP3, ASC, and caspase-1 p10; increased levels of IL-1β, IL-18, and TNFα; decreased levels of IL-10; and increased microglial activation. These effects were blocked by the NLRP3 inflammasome inhibitor Ac-Tyr-Val-Ala-Asp-chloromethylketone. The results demonstrate proof of concept that NLRP3 inflammasome activation contributes to long-term behavioral alterations in LPS - exposed mice, probably through enhanced inflammation, and that NLRP3 inflammasome inhibition might alleviate peripheral and brain inflammation and thereby ameliorate long-term behavioral alterations in LPS - exposed mice.
27923741	0	29	NLRP3 inflammasome activation	T044	C3272080
27923741	45	54	long-term	T079	C0443252
27923741	55	65	behavioral	T053	C0004927
27923741	66	77	alterations	T078	C1515926
27923741	81	85	mice	T015	C1521751
27923741	86	94	injected	T061	C1533685
27923741	100	118	lipopolysaccharide	T109	C0023810
27923741	119	137	Lipopolysaccharide	T109	C0023810
27923741	139	142	LPS	T109	C0023810
27923741	150	156	affect	T080	C1280500
27923741	161	183	central nervous system	T022	C3714787
27923741	195	212	neuroinflammation	T046	C0021368
27923741	242	254	brain damage	T037	C0270611
27923741	259	270	dysfunction	T047	C0262405
27923741	280	285	study	T062	C2603343
27923741	312	395	nod-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome activation	T044	C3272080
27923741	399	408	long-term	T079	C0443252
27923741	409	419	behavioral	T053	C0004927
27923741	420	431	alterations	T078	C1515926
27923741	438	442	week	T079	C0439230
27923741	448	452	male	T032	C0086582
27923741	453	465	C57BL/6 mice	T015	C1521751
27923741	466	474	injected	T061	C1533685
27923741	475	492	intraperitoneally	T082	C0442120
27923741	498	501	LPS	T109	C0023810
27923741	525	536	time points	T079	C2348792
27923741	543	552	injection	T061	C1533685
27923741	557	565	assessed	T052	C1516048
27923741	566	584	locomotor function	T040	C0023946
27923741	592	634	24-point neurologic deficit scoring system	T170	C0282574
27923741	643	655	rotarod test	T062	C1258024
27923741	657	665	assessed	T052	C1516048
27923741	666	677	recognition	T041	C0524637
27923741	678	684	memory	T041	C0025260
27923741	707	723	recognition test	T170	C0451414
27923741	729	737	assessed	T052	C1516048
27923741	738	759	emotional abnormality	T048	C0013985
27923741	761	770	anhedonia	T048	C0178417
27923741	775	793	behavioral despair	T048	C0233514
27923741	804	824	tail suspension test	T059	C0022885
27923741	826	842	forced swim test	T059	C0022885
27923741	848	871	sucrose preference test	T059	C0022885
27923741	881	889	assessed	T052	C1516048
27923741	890	908	protein expression	T045	C1171362
27923741	912	917	NLRP3	T116,T123	C1528260
27923741	919	958	apoptosis-associated speck-like protein	T116,T123	C0963749
27923741	960	963	ASC	T116,T123	C0963749
27923741	970	983	caspase-1 p10	T116,T126	C0534519
27923741	987	998	hippocampus	T023	C0019564
27923741	1002	1018	Western blotting	T059,T063	C0005863
27923741	1020	1028	measured	T080	C0444706
27923741	1029	1035	levels	T080	C0441889
27923741	1039	1058	interleukin (IL)-1β	T116,T129	C0021753
27923741	1060	1065	IL-18	T116,T129	C0383327
27923741	1067	1090	tumor necrosis factor α	T116,T129	C1456820
27923741	1092	1096	TNFα	T116,T129	C1456820
27923741	1103	1108	IL-10	T116,T129	C0085295
27923741	1112	1123	hippocampus	T023	C0019564
27923741	1125	1133	measured	T080	C0444706
27923741	1134	1138	TNFα	T116,T129	C1456820
27923741	1143	1148	IL-1β	T116,T129	C0021753
27923741	1152	1157	serum	T031	C0229671
27923741	1161	1166	ELISA	T059	C0014441
27923741	1182	1192	microglial	T025	C0206116
27923741	1193	1201	activity	T043	C0007613
27923741	1205	1216	hippocampus	T023	C0019564
27923741	1220	1243	Iba1 immunofluorescence	T059	C0079603
27923741	1259	1262	LPS	T109	C0023810
27923741	1265	1273	injected	T061	C1533685
27923741	1274	1278	mice	T015	C1521751
27923741	1289	1298	long-term	T079	C0443252
27923741	1299	1309	depression	T048	C0011570
27923741	1316	1325	behaviors	T053	C0004927
27923741	1330	1341	recognition	T041	C0524637
27923741	1342	1356	memory deficit	T048	C0233794
27923741	1367	1377	expression	T045	C1171362
27923741	1381	1386	NLRP3	T116,T123	C1528260
27923741	1388	1391	ASC	T116,T123	C0963749
27923741	1397	1410	caspase-1 p10	T116,T126	C0534519
27923741	1412	1421	increased	T081	C0205217
27923741	1422	1428	levels	T080	C0441889
27923741	1432	1437	IL-1β	T116,T129	C0021753
27923741	1439	1444	IL-18	T116,T129	C0383327
27923741	1450	1454	TNFα	T116,T129	C1456820
27923741	1456	1465	decreased	T081	C0205216
27923741	1466	1472	levels	T080	C0441889
27923741	1476	1481	IL-10	T116,T129	C0085295
27923741	1487	1496	increased	T081	C0205217
27923741	1497	1518	microglial activation	T043	C1326169
27923741	1526	1533	effects	T080	C1280500
27923741	1554	1582	NLRP3 inflammasome inhibitor	T121	C1254351
27923741	1583	1620	Ac-Tyr-Val-Ala-Asp-chloromethylketone	T116,T121	C0388131
27923741	1626	1633	results	T169	C1274040
27923741	1668	1697	NLRP3 inflammasome activation	T044	C3272080
27923741	1713	1722	long-term	T079	C0443252
27923741	1723	1733	behavioral	T053	C0004927
27923741	1734	1745	alterations	T078	C1515926
27923741	1749	1752	LPS	T109	C0023810
27923741	1755	1762	exposed	T080	C0332157
27923741	1763	1767	mice	T015	C1521751
27923741	1795	1807	inflammation	T046	C0021368
27923741	1818	1836	NLRP3 inflammasome	T026	C3156614
27923741	1837	1847	inhibition	T044	C0021469
27923741	1864	1874	peripheral	T082	C0205100
27923741	1879	1884	brain	T023	C0006104
27923741	1885	1897	inflammation	T046	C0021368
27923741	1921	1930	long-term	T079	C0443252
27923741	1931	1941	behavioral	T053	C0004927
27923741	1942	1953	alterations	T078	C1515926
27923741	1957	1960	LPS	T109	C0023810
27923741	1963	1970	exposed	T080	C0332157
27923741	1971	1975	mice	T015	C1521751